National Consensus Meeting to Decide Outcome Measures for Adults with SMA
On September 9th and 10th in Ottawa, Ontario, 14 adult SMA experts including, clinicians, allied health care providers, patient organization representatives, and the Canadian Neuromuscular Disease Registry (CNDR) representatives gathered to reach an updated national consensus on outcome measures for adults with SMA. With increasing experience following adults on novel disease-modifying therapy alongside advances in standardized outcome measures, it was essential to revisit the prior Canadian adult SMA toolkit (2020, link), with a renewed emphasis on meaningful outcomes for patients. The consensus work will help to support discussions within individual provinces to understand response to therapy, advocate for appropriate access to high-cost therapeutics, and enable national comparisons.
During this multi-day meeting, the group considered a broad spectrum of outcome measures that may be applicable to adult SMA to determine a core set of recommended, suggested, and exploratory measures, based on the individual’s current functional status. To support measure selection, patient preferences and perspectives, practitioner experiences, feasibility (including time and equipment needed), and provincial payer requirements were discussed.
The meeting concluded with a vote to determine which outcome measures should be completed across Canada for adults with SMA, and consensus was reached. Based on the new consensus results, the CNDR will update its SMA dataset accordingly. Official results from this national consensus-building meeting will be released soon.
Read next...
Fourth Annual Clinical & Postdoctoral Fellowship Competition from NMD4C, MDC to Open Fall 2024
NMD4C together with Muscular Dystrophy Canada are excited to announce that our annual Neuromuscular Fellowship Competition will open again for a fourth year on September 3, 2024!
NMD4C Wraps up Second Year of Training Series for Canadian Neuromuscular Clinical Fellows
We’re excited to share that the second annual National Neuromuscular Lecture Series (NNLS) finished last week!
NMD4C Host Inaugural Basic Research Summer School
Over May 27-28 2024, the NMD4C animal and cell-based research team hosted the first-ever annual basic research summer school for neuromuscular research trainees at McGill University in Montréal, QC.
NMD4C Investigator Dr. Reshma Amin Leads Successful CIHR Grant Application to Establish a Framework for Real-World Evidence for Canadian Neuromuscular Diseases
Real-World Evidence for Canadian Neuromuscular Disease: Establishing a Framework for National Integration of Patient Reported Outcomes, Clinical Registry Data, Healthcare Utilization and Healthcare Associated Costs The NMD4C is excited to share that network investigator Dr. Reshma Amin has been awarded funding from the CIHR to establish a framework for real-world evidence (RWE) for Canadian…
Spinal Muscular Atrophy Outcome Measures Workshop (English Language)
The NMD4C will be hosting an English-language interactive training workshop on standardizing assessment practices in SMA outcome measures.
NMD4C Launch Survey to Assess Familiarity and Experience in Outcome Measures in NMDs
As we anticipate novel treatments for other neuromuscular conditions, we would like to understand your familiarity and experience with the outcome measures in clinical trials underway or for treatments for NMDs approved in other jurisdictions through a short survey.